Global Information
회사소개 | 문의 | 위시리스트

미국의 임상화학 및 면역진단 시장 : 병원, 민간 실험실, Point of Care(POC)

2018 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents: Supplier Sales and Shares, Sales Segment Forecasts--Hospitals, Commercial Laboratories, POC Locations--Competitive Landscape, Emerging Technologies, Instrumentation Review

리서치사 Venture Planning Group
발행일 상품 코드 458538
페이지 정보 영문 635 Pages
가격
US $ 7,500 ₩ 9,052,000 DataPack (Local License)
US $ 8,500 ₩ 10,259,000 PDF by E-mail (Local License)
US $ 16,500 ₩ 19,915,000 DataPack (Global License)
US $ 25,300 ₩ 30,537,000 PDF by E-mail (Global License)


미국의 임상화학 및 면역진단 시장 : 병원, 민간 실험실, Point of Care(POC) 2018 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents: Supplier Sales and Shares, Sales Segment Forecasts--Hospitals, Commercial Laboratories, POC Locations--Competitive Landscape, Emerging Technologies, Instrumentation Review
발행일 : 페이지 정보 : 영문 635 Pages

미국의 임상화학(Clinical Chemistry) 및 면역진단 시장(병원, 민간 실험실, Point of Care(POC))의 주요 사업 기회에 대해 조사 분석했으며, 100개 이상의 임상화학, 치료적 약물농도 모니터링(TDM), 내분비, 종양, 면역단백, 약물 남용에 대한 5개년 예측(검사 건수, 매출액) 등의 정보를 전해드립니다.

제1장 서론

제2장 주요 제품 개발 기회

제3장 분산형 검사 제품의 설계 기준

제4장 대체적인 시장 보급 전략

  • 내부개발
  • 합작투자 협정
  • 대학과의 계약
  • 분산형 검사 제품 시장의 유통 전략
    • 마케팅 접근
    • 제품의 복잡성
    • 고객의 선호
    • 기존 공급업체
    • 신흥 공급업체
    • 유통업체의 주요 유형
    • 시장 세분화

제5장 잠재적인 시장 진출 장벽과 리스크

  • 시장 성숙
  • 비용 억제
  • 경쟁
  • 기술적 우위성과 한계
  • 특허권 보호
  • 규제상 제약
  • 분산형 검사 시장이 해결해야 할 과제

제6장 세계 시장과 기술 개요

  • 주요 일반 화학검사
  • 치료적 약물농도 모니터링(TDM)
  • 내분비기능 검사
  • 종양마커와 특수 화학검사
  • 면역 단백 검사
  • 약물 남용
  • 검사 장비 리뷰 : 동작 특성과 기능
  • 주요 체외진단 기술과 잠재적 용도
  • 세계 시장 개요
    • 비지니스 환경
    • 시장 구조
    • 시장 규모와 성장률

제7장 미국

  • 주요 요약
  • 비지니스 환경
  • 시장 구조
  • 분산형 검사의 이론적 근거
  • 시장 규모 및 성장률, 주요 공급업체의 검사 장비/시약 매출액과 시장 점유율

제8장 경쟁 전략

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE
LSH 17.03.24

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500.

VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic hospital, commercial and point-of-care/POC markets during the next five years. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices,  ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing hones, and birth centers, including controls, calibrators and consumables.

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Strategic Recommendations

- New product development opportunities with significant market appeal. Alternative market penetration strategies. Potential market entry barriers and risks.

Tests Analyzed in the Report

Routine Clinical Chemistry

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.

Therapeutic Drug Monitoring (TDM)

Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.

Endocrine Function

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake,  Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab,  TPO Ab, TSH.

Tumor Markers and Special Chemistry

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.

Immunoproteins

C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.

Market Segmentation Analysis

- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.

- Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by market segment:

Centralized Testing

- Hospitals Commercial/Private Laboratories

POC/Decentralized Testing

- Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers

Current and Emerging Products

- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.

- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

Technology Review

- Assessment of current and emerging technologies, and their potential  market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Strategies

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

- The companies analyzed in the report include:

   -Abbott    - AdnaGen    - Agilent Technologies    - Bayer Healthcare    - Beckman Coulter/Danaher    - Biomedical Diagnostics    - Biomerieux    - Bio-Rad    - Diasorin    - Eiken Chemical    - Fujirebio    - Grifols    - Instrumentation Laboratory    - Kyowa Medex    - Matritech/Alere    - Ortho-Clinical Diagnostics    - Quest Diagnostics    - Roche    - Siemens    - Sysmex    - Thermo Fisher    - Tosoh    - Wako    - Wallac/PE

Contains 635 pages and 149 tables

Table of Contents

I. Introduction

II. Major Product Development Opportunities

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

V. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VI. Worldwide Market and Technology Overview

  • A. Major Routine Chemistry Tests
    • 1. Albumin
    • 2. Alkaline Phosphatase
    • 3. ALT/SGPT
    • 4. Ammonia
    • 5. Amylase
    • 6. AST/SGOT
    • 7. Bilirubin, Total
    • 8. Blood Gases
    • 9. Blood Urea Nitrogen (BUN)
    • 10. Calcium
    • 11. Cardio CRP
    • 12. Cholesterol
    • 13. Cholinesterase
    • 14. CRP
    • 15. Creatinine
    • 16. Electrolytes
      • a. Carbon Dioxide/Bicarbonate
      • b. Chloride
      • c. Potassium
      • d. Sodium
    • 17. Ferritin
    • 18. Fructosamine
    • 19. Gamma-Glutamyl Transpeptidase (GGT)
    • 20. Glucose
    • 21. High Density Lipoprotein (HDL)
    • 22. Homocysteine
    • 23. Iron
    • 24. Lactate Dehydrogenase (LDH)
    • 25. Magnesium
    • 26. Phosphorus
    • 27. Protein
    • 28. Triglycerides
    • 29. Uric Acid
    • 30. Troponin
  • B. Therapeutic Drug Monitoring (TDM)
    • 1. Overview
    • 2. Carbamazepine
    • 3. Cyclosporin
    • 4. Digoxin
    • 5. Everolimus
    • 6. Gentamicin
    • 7. Lamotrigine/Lamictal
    • 8. Levetiracetam
    • 9. Lidocaine
    • 10. Lithium
    • 11. NAPA/Procainamide
    • 12. Phenytoin
    • 13. Quinidine
    • 14. Sirolimus
    • 15. Tacrolimus
    • 16. Theophylline
    • 17. Topirimate
    • 18. Valproic Acid
  • C. Endocrine Function Tests
    • 1. Cortisol
    • 2. Estradiol
    • 3. Follicle-Stimulating Hormone (FSH)
    • 4. Gastrin
    • 5. Growth Hormone/IGF-1
    • 6. Human Chorionic Gonadotropin (HCG)
    • 7. LH
    • 8. Progesterone
    • 9. PTH/IO PTH
    • 10. Prolactin
    • 11. T3
    • 12. T3 Free
    • 13. T3 Uptake
    • 14. T4 (Thyroxine)
    • 15. T4 Free
    • 16. TBG
    • 17. Testosterone
    • 18. Thyroglobulin Ab
    • 19. TPO Ab
    • 20. TSH
  • D. Tumor Markers And Special Chemistry Tests
    • 1. AFP
    • 2. CA 15-3
    • 3. CA 19-9
    • 4. CA 27-29
    • 5. Carcinoembrionic Antigen (CEA)
    • 6. Folate/Folic Acid
    • 7. HCG
    • 8. 25-Hydroxy Vitamin D2 and D3
    • 9. Occult Blood
    • 10. Prostate-Specific Antigen (PSA)
    • 11. Thyroglobulin
    • 12. Vitamin B-12
  • E. Immunoprotein Tests
    • 1. Complement
      • a. C3
      • b. C4
    • 2. Free Light Chains
    • 3. Immunofixation
    • 4. Immunoglobulins (IgA, IgE, IgG, IgM)
    • 5. Haptoglobin
    • 6. Prealbumin
    • 7. Protein Electrophoresis
  • F. Drugs of Abuse
    • 1. Overview
    • 2. Test Methodologies
    • 3. Amphetamines
    • 4. Barbiturates
    • 5. Benzodiazepines
    • 6. Cannabinoids/Marijuana
    • 7. Cocaine
    • 8. Lysergic Acid Diethylamide (LSD)
    • 9. Methadone
    • 10. Methaqualone
    • 11. Opiates
    • 12. Phencyclidine
    • 13. Tricyclic Antidepressants
  • G. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers
  • H. Major In Vitro Diagnostic Technologies And Their Potential Applications
    • 1. Monoclonal and Polyclonal Antibodies
    • 2. Immunoassays
      • a. Technological Principle
      • b. Chemiluminescence
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Electrochemical
      • d. Radioimmunoassays (RIA)
      • e. Immunoprecipitation
      • f. Affinity Chromatography
    • 3. Tandem Mass Spec
    • 4. IT and Automation
    • 5. Dry Chemistry
    • 6. Biosensors

VII. U.S.A.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Rationale for Testing Decentralization
    • 1. Overview
    • 2. Regulatory Trends
    • 3. Economic Trends
    • 4. Demographic Trends
    • 5. Technological Trends
    • 6. Social Trends
    • 7. Quality of Care
    • 8. Defensive Medicine
    • 9. Quality Control Issues
  • E. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares

VIII. Competitive Strategies

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

List of Tables

  • Major Companies Developing or Marketing Albumin Tests
  • Major Companies Developing or Marketing Alkaline Phosphatase Tests
  • Major Companies Developing or Marketing ALT/SGPT Tests
  • Major Companies Developing or Marketing Amylase Tests
  • Major Companies Developing or Marketing AST/SGOT Tests
  • Major Companies Developing or Marketing Bilirubin Tests
  • Major Companies Developing or Marketing Blood Gas Analyzers
  • Major Companies Developing or Marketing BUN Tests
  • Major Companies Developing or Marketing Calcium Tests
  • Major Companies Developing or Marketing Cholesterol Tests
  • Major Companies Developing or Marketing Creatinine Tests
  • Major Companies Developing or Marketing Electrolyte Tests
  • Major Companies Developing or Marketing GGT Tests
  • Major Companies Developing or Marketing Glucose Tests
  • Major Companies Developing or Marketing HDL Tests
  • Major Companies Developing or Marketing Iron Tests
  • Major Companies Developing or Marketing LDH Tests
  • Major Companies Developing or Marketing Magnesium Tests
  • Major Companies Developing or Marketing Phosphorus Tests
  • Major Companies Developing or Marketing Protein Tests
  • Major Companies Developing or Marketing Triglycerides Tests
  • Major Companies Developing or Marketing Uric Acid Tests
  • Major Companies Developing or Marketing TDM Tests
  • Major Companies Developing or Marketing Digoxin Tests
  • Major Companies Developing or Marketing Lithium Tests
  • Major Companies Developing or Marketing Phenytoin/Dilantin Tests
  • Major Companies Developing or Marketing Theophylline Tests
  • Major Companies Developing or Marketing Valproic Acid Tests
  • Major Companies Developing or Marketing FSH Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing LH Tests
  • Major Companies Developing or Marketing Prolactin Tests
  • Major Companies Developing or Marketing T3 Tests
  • Major Companies Developing or Marketing T4 Tests
  • Major Companies Developing or Marketing TSH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Vitamin B-12/Folate Tests
  • Major Companies Developing or Marketing CRP Tests
  • Major Companies Developing or Marketing Drugs of Abuse Tests
  • Major Companies Developing or Marketing Biosensors for Immunological Testing
  • Executive Summary Table: U.S.A., Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
  • U.S.A., Laboratories Performing Chemistry and Immunoassay Testing By Market Segment
  • U.S.A., Hospital Laboratories Performing Chemistry and Immunoassay Tests By Bed Size
  • U.S.A., Commercial/Private Laboratories Performing Chemistry and Immunoassay Tests By Annual Test Volume
  • U.S.A., Total Chemistry and Immunoassay Specimen Volume Forecast
  • U.S.A., All Market Segments, Specimen Volume Forecast By Test Category
  • U.S.A., Total Clinical Chemistry and Immunoassay Test Volume Forecast By Test Category
  • U.S.A., Routine Chemistry Test Volume Forecast By Market Segment
  • U.S.A., TDM Test Volume Forecast By Market Segment
  • U.S.A., Endocrine Function Test Volume Forecast By Market Segment
  • U.S.A., Drugs of Abuse Test Volume Forecast By Market Segment
  • U.S.A., Tumor Markers and Special Chemistry Test Volume Forecast By Market Segment
  • U.S.A., Immunoprotein Test Volume Forecast By Market Segment
  • U.S.A., All Market Segments, Profiles, Panels and Individual Tests Forecast
  • U.S.A., Hospital Laboratories, Profiles, Panels and Individual Tests Forecast
  • U.S.A., Commercial/Private Laboratories, Profiles, Panels and Individual Tests Forecast
  • U.S.A., Physician Offices/Group Practices, Profiles, Panels and Individual Tests Forecast
  • U.S.A., All Market Segments, Routine Chemistry Test Volume Forecast by Assay
  • U.S.A., Hospital Laboratories, Routine Chemistry Test Volume Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Routine Chemistry Test Volume Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Routine Chemistry Test Volume Forecast by Assay
  • U.S.A., All Market Segments, TDM Test Volume Forecast by Assay
  • U.S.A., Hospital Laboratories, TDM Test Volume Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, TDM Test Volume Forecast by Assay
  • U.S.A., All Market Segments, Endocrine Function Test Volume Forecast by Assay
  • U.S.A., Hospital Laboratories, Endocrine Function Test Volume Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Endocrine Function Test Volume Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Endocrine Function Test Volume Forecast by Assay
  • U.S.A., All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
  • U.S.A., Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Drugs of Abuse Test Volume Forecast by Assay
  • U.S.A., All Market Segments, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
  • U.S.A., Hospital Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
  • U.S.A., All Market Segments, Immunoprotein Test Volume Forecast by Assay
  • U.S.A., Hospital Laboratories, Immunoprotein Test Volume Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Immunoprotein Test Volume Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Immunoprotein Test Volume Forecast by Assay
  • U.S.A., Total Clinical Chemistry and Immunoassay Reagent Market Forecast By Test Category
  • U.S.A., Clinical Chemistry and Immunoassay Calibrator and Control Market Forecast By Test Category
  • U.S.A., Routine Chemistry Reagent Market Forecast By Market Segment
  • U.S.A., TDM Reagent Market Forecast By Market Segment
  • U.S.A., Drugs of Abuse Reagent Market Forecast By Market Segment
  • U.S.A., Tumor Markers and Special Chemistry Reagent Market Forecast By Market Segment
  • U.S.A., Endocrine Function Reagent Market Forecast By Market Segment
  • U.S.A., All Market Segments, Routine Chemistry Reagent Market Forecast by Assay
  • U.S.A., Hospital Laboratories, Routine Chemistry Reagent Market Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Routine Chemistry Reagent Market Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Routine Chemistry Reagent Market Forecast by Assay
  • U.S.A., All Market Segments, TDM Reagent Market Forecast by Assay
  • U.S.A., Hospital Laboratories, TDM Reagent Market Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
  • U.S.A., Physician Office/Group Practices, TDM Reagent Market Forecast by Assay
  • U.S.A., All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
  • U.S.A., Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Drugs of Abuse Reagent Market Forecast by Assay
  • U.S.A., All Market Segments, Endocrine Function Reagent Market Forecast by Assay
  • U.S.A., Hospital Laboratories, Endocrine Function Reagent Market Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Endocrine Function Reagent Market Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Endocrine Function Reagent Market Forecast by Assay
  • U.S.A., All Market Segments, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
  • U.S.A., Hospital Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
  • U.S.A., All Market Segments, Immunoprotein Reagent Market Forecast
  • U.S.A., Hospital Laboratories,Immunoprotein Reagent Market Forecast Immunoprotein
  • U.S.A., Commercial/Private Laboratories, Immunoprotein Reagent Market Forecast
  • U.S.A., Physician Offices/Group Practices, Immunoprotein Reagent Market Forecast by Assay
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
  • U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Hospital ICUs/CCUs Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Routine And Special Reagent Market Forecast by Test
  • U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Cancer Clinics Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Routine And Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Surgery Centers Routine And Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
  • U.S.A., Nursing Homes Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Nursing Homes Routine And Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Birth Centers Profiles, Panels and Individual Tests
  • U.S.A., Birth Centers Routine And Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Instrument Sales and Market Shares
  • U.S.A., Major Suppliers of Clinical Chemistry Diagnostics Products, Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Instrument Sales and Market Shares
  • U.S.A., Major Suppliers of Immunoassay Diagnostics Products, Estimated Sales And Market Shares
  • U.S.A., Clinical Chemistry and Immunoassay Instrument Market Forecast By Analyzer Type
Back to Top
전화 문의
F A Q